Eukaryotic elongation factor 2 kinase inhibitor, A484954 lowered blood pressure in spontaneously hypertensive rats via inducing vasorelaxation
Author:
Funder
JSPS KAKENHI
Kitasato University Research
Publisher
Elsevier BV
Subject
Pharmacology,Molecular Medicine
Reference30 articles.
1. Identification of the major M(r) 100,000 substrate for calmodulin-dependent protein kinase III in mammalian cells as elongation factor-2;Nairn;J Biol Chem,1987
2. Identification of the phosphorylation sites in elongation factor-2 from rabbit reticulocytes;Price;FEBS Lett,1991
3. Identification of a new class of protein kinases represented by eukaryotic elongation factor-2 kinase;Ryazanov;Proc Natl Acad Sci U S A,1997
4. Exploring calmodulin-related proteins, which mediate development of hypertension, in vascular tissues of spontaneous hypertensive rats;Usui;Biochem Biophys Res Commun,2011
5. Eukaryotic elongation factor 2 kinase regulates the development of hypertension through oxidative stress-dependent vascular inflammation;Usui;Am J Physiol Heart Circ Physiol,2013
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Structure of the complex between calmodulin and a functional construct of eukaryotic elongation factor 2 kinase bound to an ATP-competitive inhibitor;Journal of Biological Chemistry;2023-06
2. eEF2K Inhibitor Design: The Progression of Exemplary Structure-Based Drug Design;Molecules;2023-01-21
3. Eukaryotic elongation factor 2 kinase inhibitor, A484954 induced diuresis via nitric oxide production in spontaneously hypertensive rats;Journal of Veterinary Medical Science;2023
4. Eukaryotic elongation factor 2 kinase inhibitor, A484954 inhibits perivascular sympathetic nerve stimulation-induced vasoconstriction in isolated renal artery;European Journal of Pharmacology;2022-07
5. Eukaryotic elongation factor 2 kinase inhibitor, A484954 induces diuretic effect via renal vasorelaxation in spontaneously hypertensive rats;European Journal of Pharmacology;2021-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3